Gregory Verdine is the founder of Fog Pharmaceuticals. Fog Pharmaceuticals has raised $361M in total funding. Latest round: Series D. Based in Cambridge, MA.
Gregory Verdine is a serial biotech entrepreneur who founded Fog Pharmaceuticals, spinning it out of Harvard University in 2016. He is known for developing Helicon™ polypeptide therapeutics and has helped his companies raise over $600 million combined. As of late 2022, he was the Founder & CEO of FogPharma, later transitioning from CEO to remain on the board.
Full founder directory · Investor directory · Company funding database · Fundraising library